Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE-PA) Gross Profit (2016 - 2025)

Historic Gross Profit for Global Medical REIT (GMRE-PA) over the last 10 years, with Q3 2025 value amounting to $29.0 million.

  • Global Medical REIT's Gross Profit rose 811.87% to $29.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.8 million, marking a year-over-year increase of 490.44%. This contributed to the annual value of $109.5 million for FY2024, which is 304.34% down from last year.
  • Per Global Medical REIT's latest filing, its Gross Profit stood at $29.0 million for Q3 2025, which was up 811.87% from $29.8 million recorded in Q2 2025.
  • In the past 5 years, Global Medical REIT's Gross Profit registered a high of $29.8 million during Q2 2025, and its lowest value of $23.7 million during Q1 2021.
  • Over the past 5 years, Global Medical REIT's median Gross Profit value was $27.7 million (recorded in 2022), while the average stood at $27.4 million.
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 2656.83% in 2021, then crashed by 788.54% in 2023.
  • Quarter analysis of 5 years shows Global Medical REIT's Gross Profit stood at $25.8 million in 2021, then rose by 12.97% to $29.2 million in 2022, then fell by 7.89% to $26.9 million in 2023, then increased by 4.07% to $28.0 million in 2024, then increased by 3.73% to $29.0 million in 2025.
  • Its Gross Profit stands at $29.0 million for Q3 2025, versus $29.8 million for Q2 2025 and $27.0 million for Q1 2025.